China SXT Pharmaceuticals (SXTC) News Today $1.64 -0.05 (-2.66%) Closing price 07/18/2025 03:57 PM EasternExtended Trading$1.62 -0.02 (-1.52%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Price Down 10.1% - Here's WhyJuly 8, 2025 | marketbeat.comChina SXT Pharmaceuticals, Inc. (SXTC) - Yahoo FinanceJuly 4, 2025 | sg.finance.yahoo.comChina SXT Pharmaceuticals Inc News (SXTC) - Investing.comJune 25, 2025 | investing.comChina SXT Pharmaceuticals Issues 90 Million Shares Following Warrant ExerciseJune 16, 2025 | tipranks.comChina SXT Pharmaceuticals Inc Ordinary SharesApril 23, 2025 | morningstar.comMChina SXT Pharmaceuticals Reports Financial Results Amid Regulatory ChallengesMarch 28, 2025 | tipranks.comChina SXT Pharmaceuticals Optimizes Capital Structure with Warrant ExchangeMarch 19, 2025 | tipranks.comChina SXT Pharmaceuticals regains compliance with NasdaqMarch 17, 2025 | markets.businessinsider.comChina SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price DeficiencyMarch 17, 2025 | finance.yahoo.comChina SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price DeficiencyMarch 17, 2025 | globenewswire.comChina SXT Pharmaceuticals Inc trading resumesFebruary 25, 2025 | markets.businessinsider.comChina SXT Pharmaceuticals Inc trading halted, volatility trading pauseFebruary 25, 2025 | markets.businessinsider.comChina SXT Pharmaceuticals Inc trading halted, news pendingFebruary 24, 2025 | markets.businessinsider.comChina SXT Pharmaceuticals Announces New Securities Purchase AgreementJanuary 27, 2025 | msn.comChina SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyOctober 7, 2024 | globenewswire.comChina SXT Pharmaceuticals (NASDAQ:SXTC) Stock, Short Interest ReportOctober 1, 2024 | benzinga.comJAGX, BSGM and SXTC among mid-day moversApril 16, 2024 | msn.comChina SXT Pharmaceuticals (Nasdaq:SXTC) HeadlineTrading was temporarily halted for "SXTC" at 09:04 AM with a stated reason of "LULD pause."...April 16, 2024 | marketbeat.comChina SXT Pharmaceuticals Inc.February 23, 2024 | wsj.comChina SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider TradesFebruary 23, 2024 | benzinga.comChina SXT Pharmaceuticals, Inc. (SXTC)February 17, 2024 | finance.yahoo.comDow Down 100 Points; US Manufacturing PMI Falls In DecemberJanuary 2, 2024 | markets.businessinsider.comChina SXT Pharma Continues To SpikeDecember 31, 2023 | nasdaq.comChina SXT Pharmaceuticals Inc Ordinary Shares SXTCDecember 19, 2023 | morningstar.comMChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleOctober 26, 2023 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleOctober 26, 2023 | finance.yahoo.comChina SXT Pharmaceuticals (Nasdaq:SXTC) HeadlineTrading was temporarily halted for "SXTC" at 09:10 AM with a stated reason of "LULD pause."...October 5, 2023 | marketbeat.comChina SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitOctober 4, 2023 | finanznachrichten.deChina SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5October 4, 2023 | markets.businessinsider.comChina SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitOctober 4, 2023 | finance.yahoo.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?September 7, 2023 | investorplace.comSXTC China SXT Pharmaceuticals, Inc.August 25, 2023 | seekingalpha.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?August 21, 2023 | markets.businessinsider.comChina SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)August 2, 2023 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleMay 10, 2023 | finance.yahoo.comInsiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% dropMarch 29, 2023 | finance.yahoo.comChina says talks to include Paxlovid in its insurance drug list failJanuary 10, 2023 | reuters.comChina SXT Pharmaceuticals Stock (NASDAQ:SXTC), Quotes and News SummaryJanuary 5, 2023 | benzinga.comChina SXT Pharmaceuticals announces 1-for-20 reverse stock splitMay 18, 2022 | seekingalpha.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up Today?March 29, 2022 | investorplace.comChina SXT Pharmaceuticals climbs on heavy volumeMarch 29, 2022 | seekingalpha.comChina SXT Pharmaceuticals to raise $2.8M in convertible promissory note offeringMarch 15, 2022 | seekingalpha.comChina SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 MillionMarch 14, 2022 | benzinga.comChina SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-AllotmentJanuary 20, 2022 | finance.yahoo.comAegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).January 20, 2022 | finance.yahoo.comChina SXT Pharmaceuticals Shares Plunge On $3.5M Equity Raise Issued At Steep DiscountJanuary 18, 2022 | finance.yahoo.comChina SXT Pharmaceuticals slumps on pricing $3.5M stock, pre-funded warrants offeringJanuary 18, 2022 | seekingalpha.comChina SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesJanuary 18, 2022 | finance.yahoo.comChina SXT Pharma announces proposed public offering of shares, prefunded warrantsJanuary 14, 2022 | seekingalpha.comChina SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesJanuary 14, 2022 | finance.yahoo.com Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address SXTC Media Mentions By Week SXTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SXTC News Sentiment▼0.000.61▲Average Medical News Sentiment SXTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SXTC Articles This Week▼00▲SXTC Articles Average Week Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Vir Biotechnology News KalVista Pharmaceuticals News Amylyx Pharmaceuticals News ArriVent BioPharma News Immatics News Immunome News Nuvation Bio News MeiraGTx News Gyre Therapeutics News Autolus Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SXTC) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
